TMEM63C and breast carcinoma: Then, it was found that the G. lucidum immunomodulatory protein FIP-glu significantly regulated the mRNA levels of risk genes and reversed the tumor-promoting activity of TMEM63C in breast cancer T-47D and MCF-7 cells.